Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2019-09-20 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
FREE WRITING PROSPECTUS
Regulatory Filings Classification · 95% confidence The document is titled 'FREE WRITING PROSPECTUS' and is very short (1272 characters). A Free Writing Prospectus (FWP) is a disclosure document used in securities offerings to provide additional information to investors. It is not a financial report, earnings release, or management discussion. It is related to capital raising activities but is distinct from formal capital/financing updates or filings like prospectuses or registration statements. Given the nature and length, it is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2019-09-20 English
AMENDMENT NO. 2 TO FORM F-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 2 to Form F-1/A filed with the U.S. Securities and Exchange Commission. Form F-1 is a registration statement used by foreign private issuers to register securities under the Securities Act of 1933. The text includes detailed information about the securities offering, registration fees, underwriting, risk factors, and financial data. It is clearly a registration statement related to a securities offering, not a financial report, earnings release, or other types of filings. This type of document is best classified under Capital/Financing Update (CAP) because it pertains to the registration and offering of securities to the public, which is a capital raising activity.
2019-09-20 English
AMENDMENT NO. 1 TO FORM F-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form F-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933, related to the offering of American Depositary Shares by Tiziana Life Sciences plc. The document includes a preliminary prospectus with detailed information about the offering, company overview, risk factors, financial data, and legal matters. This type of filing is a registration statement for securities offering, which falls under the category of Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes. It is not an annual report, earnings release, or other report types defined in the list. The document length and content confirm it is the actual registration statement amendment, not just an announcement or certification.
2019-09-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement about FDA approval to initiate a clinical trial. The document itself is short (2982 characters) and primarily furnishes an external announcement (Exhibit 99.1) rather than containing substantive financial data or detailed report content. It explicitly states that the information is being furnished and not filed, indicating it is an announcement rather than a full report. According to the rules, such documents that provide regulatory announcements or compliance information without detailed financial or operational data should be classified as Regulatory Filings (RNS).
2019-09-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement dated September 10, 2019, regarding clinical data. The document itself is short (3069 characters) and primarily furnishes the RNS announcement as Exhibit 99.1. It explicitly states that the information is being furnished and not filed, and it is not the full report but an announcement. According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings and announcements that do not fit other specific categories.
2019-09-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement dated September 4, 2019, regarding positive clinical data. The document itself is short (3083 characters) and primarily furnishes the RNS announcement as Exhibit 99.1. It explicitly states that the information is being furnished and not filed, and it is not a full report but an announcement of information. There are no financial statements or detailed financial data present. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit into other specific categories and is not a full report or financial statement.
2019-09-04 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.